The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Open accessAbstract
Background: The association of genetic polymorphisms and clopidogrel efficacy in patients with ischemic stroke or transient ischemic attack (TIA) remains controversial. We performed a systematic review and meta-analysis to assess the association between genetic polymorphisms, especially CYP2C19 genotype, and clopidogrel efficacy for ischemic stroke or TIA. Methods: We conducted a comprehensive search of PubMed and EMBASE from their inceptions to June 24, 2016. Studies that reported clopidogrel-treated patients with stroke or TIA and with information on genetic polymorphisms were included. The end points were stroke, composite vascular events, and any bleeding. Results: Among 15 studies of 4762 patients with stroke or TIA treated with clopidogrel, carriers of CYP2C19 loss-of-function alleles (*2, *3, and *8) were at increased risk of stroke in comparison with noncarriers (12.0% versus 5.8%; risk ratio, 1.92, 95% confidence interval, 1.57–2.35; P <0.001). Composite vascular events were also more frequent in carriers of CYP2C19 loss-of-function alleles than in noncarriers (13.7% versus 9.4%; risk ratio, 1.51, 95% confidence interval, 1.10–2.06; P =0.01), whereas bleeding rates were similar (2.4% versus 3.1%; risk ratio, 0.89, 95% confidence interval, 0.58–1.35; P =0.59). There was no evidence of statistical heterogeneity among the included studies for stroke, but there was for composite vascular events. Genetic variants other than CYP2C19 were not associated with clinical outcomes, with the exception that significant associations of PON1 , P2Y12 , and COX-1 with outcomes were observed in 1 study. Conclusions: Carriers of CYP2C19 loss-of-function alleles are at greater risk of stroke and composite vascular events than noncarriers among patients with ischemic stroke or TIA treated with clopidogrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2014) · Medical Entomology and Zoology · Cited by 17,633
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., Wang, C., Li, H., Meng, X., Cui, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215340 · Cited by 1,854
Self-citationGenetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
Scott, S. A., Sangkuhl, K., Gardner, E. E., Stein, C. M., Hulot, J.-S., Johnson, J. A., Roden, D. M., Klein, T. E., & Shuldiner, A. R. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.132 · Cited by 484
Holmes, M. V., Perel, P., Shah, T., Hingorani, A. D., & Casas, J. P. (2011) · JAMA · doi:10.1001/jama.2011.1880 · Cited by 472
Hulot, J.-S., Collet, J.-P., Silvain, J., Pena, A., Bellemain-Appaix, A., Barthélémy, O., Cayla, G., Beygui, F., & Montalescot, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.071 · Cited by 383
Wang, Y., Zhao, X., Lin, J., Li, H., Johnston, S. C., Lin, Y., Pan, Y., Liu, L., Wang, D., Wang, C., et al. (2016) · JAMA · doi:10.1001/jama.2016.8662 · Cited by 375
Self-citationZhao, D., Liu, J., Wang, W., Zeng, Z., Cheng, J., Liu, J., Sun, J., & Wu, Z. (2008) · Stroke · doi:10.1161/strokeaha.107.502807 · Cited by 347
Zabalza, M., Subirana, I., Sala, J., Lluis-Ganella, C., Lucas, G., Tomás, M., Masiá, R., Marrugat, J., Brugada, R., & Elosua, R. (2012) · Heart · doi:10.1136/hrt.2011.227652 · Cited by 180
Johnston, S. C., Easton, J. D., Farrant, M., Barsan, W., Battenhouse, H., Conwit, R., Dillon, C., Elm, J., Lindblad, A., Morgenstern, L., et al. (2013) · International Journal of Stroke · doi:10.1111/ijs.12129 · Cited by 162
Self-citationPharmacogenomic testing: Relevance in medical practice
Kitzmiller, J. P., Groen, D. K., Phelps, M. A., & Sadée, W. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10145 · Cited by 151
Hasan, M. S., Basri, H., Hin, L. P., & Stanslas, J. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.744308 · Cited by 113
CYP2C19 Polymorphisms and Antiplatelet Effects of Clopidogrel in Acute Ischemic Stroke in China
Jia, D., Chen, Z. Z., Zhang, M., et al. (2013) · Stroke · doi:10.1161/strokeaha.113.000823 · Cited by 106
Antiplatelet resistance in stroke
Topçuoğlu, M. A., Arsava, E. M., & Ay, H. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.203 · Cited by 86
Yi, X., Lin, J., Wang, Y., Zhou, Q., Wang, C., Cheng, W., & Chi, L. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33290 · Cited by 56
Self-citationPrevalence, knowledge, and treatment of transient ischemic attacks in China
Wang, Y., Zhao, X., Jiang, Y., Li, H., Wang, L., Johnston, S. C., Liu, L., Wong, K. S., Wang, C., Pan, Y., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001665 · Cited by 55
Self-citationMcDonough, C. W., McClure, L. A., Mitchell, B. D., Gong, Y., Horenstein, R. B., Lewis, J. P., Field, T. S., Talbert, R. L., Benavente, O., Johnson, J. A., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001652 · Cited by 54
Zhu, W., Zhao, T. S., Xiong, X., Li, J., Wang, L., Zhou, Y. J., Gong, Z., Cheng, S., Liu, Y., Shuai, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25478 · Cited by 53
Self-citationSun, W., Li, Y., Li, J., Zhang, Z., Zhu, W., Liu, W., Cai, Q., Wang, X., Cao, L., Bai, W., et al. (2014) · Platelets · doi:10.3109/09537104.2014.953044 · Cited by 48
Komócsi, A., Vorobcsuk, A., Serebruany, V. L., & Aradi, D. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0377 · Cited by 48
Osnabrugge, R. L. J., Head, S. J., Zijlstra, F., ten Berg, J. M., Hunink, M. G. M., Kappetein, A. P., & Janssens, A. C. J. W. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.76 · Cited by 46
Han, Y., Lv, H., Liu, X., Dong, Q., Yang, X., Li, S., Wu, S., Jiang, J., Luo, Z., Zhu, D., et al. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12426 · Cited by 45
Self-citationLi, X.-Q., Ma, N., Li, X., Wang, B., Sun, S., Gao, F., Mo, D., Song, L., Sun, X., Liu, L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148891 · Cited by 45
Self-citationClinical consequences of aspirin and clopidogrel resistance: an overview
Mijajlovic, M. D., Shulga, O. D., Bloch, S., Covickovic-Sternic, N., Aleksić, V., & Bornstein, N. M. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12111 · Cited by 43
Qiu, L., Sun, Y., Wang, L., Han, R., Xia, X., Liu, J., & Li, X. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.037 · Cited by 43
Self-citationHoh, B. L., Gong, Y., McDonough, C. W., et al. (2015) · Journal of neurosurgery · doi:10.3171/2015.6.jns15795 · Cited by 32
CYP2C19 Genotype and Early Ischemic Lesion Recurrence in Stroke Patients Treated with Clopidogrel
Jeong, T., Kim, S. M., Kim, H. J., et al. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.09.014 · Cited by 29
Lin, Y., Li, J., Zhang, M. Q., et al. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12173 · Cited by 29
Spokoyny, I., Barazangi, N., Jaramillo, V., Rose, J., Chen, X. C., Wong, C., & Tong, D. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.06.008 · Cited by 28
Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke
Hankey, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1305127 · Cited by 28
Zhang, S., Lai, X., Li, W., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.001 · Cited by 24
Yi, X., Wang, Y., Lin, J., et al. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616648408 · Cited by 21
Self-citationFang, L., Zhao, Y., Wang, N., et al. (2015) · PubMed · doi:10.3760/cma.j.issn.1003-9406.2015.06.026 · Cited by 12
Cited by
Hilkens, N. A., Casolla, B., Leung, T. W., & de Leeuw, F.-E. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00642-1 · Cited by 681
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA
Johnston, S. C., Amarenco, P., Denison, H., Evans, S. R., Himmelmann, A., James, S., Knutsson, M., Ladenvall, P., Molina, C. A., & Wang, Y. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916870 · Cited by 608
Self-citationLee, C. R., Luzum, J. A., Sangkuhl, K., Gammal, R. S., Sabatine, M. S., Stein, C. M., Kisor, D. F., Limdi, N. A., Lee, Y. M., Scott, S. A., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2526 · Cited by 519
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Wang, Y., Meng, X., Wang, A., Xie, X., Pan, Y., Johnston, S. C., Li, H., Bath, P. M., Dong, Q., Xu, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111749 · Cited by 395
Self-citationPhysical Activity Design for Balance Rehabilitation in Children with Autism Spectrum Disorder
Roșca, A. M., Rusu, L., Marin, M. I., Ene Voiculescu, V., & Ene Voiculescu, C. (2022) · Children · doi:10.3390/children9081152 · Cited by 29
Metadata
- Authors
- Pan, Y., Chen, W., Xu, Y., Yi, X., Han, Y., Yang, Q., Li, X., Huang, L., Johnston, S. C., Zhao, X., Liu, L., Zhang, Q., Wang, G., Wang, Y., & Wang, Y.
- Venue
- Circulation
- Published
- 2017-01-03
- Volume
- 135
- Issue
- 1
- Pages
- 21-33
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2548744167
- Cited by
- 281
- References
- 36
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.